Literature DB >> 27528276

Lipopolysaccharide Domains Modulate Urovirulence.

Lizath M Aguiniga1, Ryan E Yaggie1, Anthony J Schaeffer1, David J Klumpp2,3.   

Abstract

Uropathogenic Escherichia coli (UPEC) accounts for 80 to 90% of urinary tract infections (UTI), and the increasing rate of antibiotic resistance among UPEC isolates reinforces the need for vaccines to prevent UTIs and recurrent infections. Previous studies have shown that UPEC isolate NU14 suppresses proinflammatory NF-κB-dependent cytokines (D. J. Klumpp, A. C. Weiser, S. Sengupta, S. G. Forrestal, R. A. Batler, and A. J. Schaeffer, Infect Immun 69:6689-6695, 2001, http://dx.doi.org/10.1128/IAI.69.11.6689-6695.2001; B. K. Billips, A. J. Schaeffer, and D. J. Klumpp, Infect Immun 76:3891-3900, 2008, http://dx.doi.org/10.1128/IAI.00069-08). However, modification of lipopolysaccharide (LPS) structure by deleting the O-antigen ligase gene (waaL) enhanced proinflammatory cytokine secretion. Vaccination with the ΔwaaL mutant diminished NU14 reservoirs and protected against subsequent infections. Therefore, we hypothesized that LPS structural determinants shape immune responses. We evaluated the contribution of LPS domains to urovirulence corresponding to the inner core (waaP, waaY, and rfaQ), outer core (rfaG), and O-antigen (waaL, wzzE, and wzyE). Deletion of waaP, waaY, and rfaG attenuated adherence to urothelial cells in vitro In a murine UTI model, the ΔrfaG mutant had the most severe defect in colonization. The mutation of rfaG, waaL, wzzE, and wzyE resulted in an inability to form reservoirs in mouse bladders. Infection with the LPS mutant panel resulted in various levels of urinary myeloperoxidase. Since the ΔwaaL mutant promoted Th1-associated adaptive responses in previous studies (B. K. Billips, R. E. Yaggie, J. P. Cashy, A. J. Schaeffer, and D. J. Klumpp, J Infect Dis 200:263-272, 2009, http://dx.doi.org/10.1086/599839), we assessed NU14 for Th2-associated cytokines. We found NU14 infection stimulated TLR4-dependent bladder interleukin-33 (IL-33) production. Inoculation with rfaG, waaL, wzzE, and wzyE mutants showed decreased IL-33 production. We quantified antigen-specific antibodies after infection and found significantly increased IgE and IgG1 in ΔwaaP mutant-infected mice. Our studies show LPS structural constituents mediate multiple aspects of the UPEC life cycle, including the ability to acutely colonize bladders, form reservoirs, and evoke innate and adaptive immune responses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27528276      PMCID: PMC5067746          DOI: 10.1128/IAI.00315-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

Review 1.  Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs.

Authors:  Betsy Foxman; Patricia Brown
Journal:  Infect Dis Clin North Am       Date:  2003-06       Impact factor: 5.982

Review 2.  Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 4.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

5.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

6.  Clonal and pathotypic analysis of archetypal Escherichia coli cystitis isolate NU14.

Authors:  J R Johnson; S J Weissman; A L Stell; E Trintchina; D E Dykhuizen; E V Sokurenko
Journal:  J Infect Dis       Date:  2001-11-01       Impact factor: 5.226

7.  Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Authors:  Drew J Schwartz; Swaine L Chen; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

8.  Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli.

Authors:  Ruth E Berry; David J Klumpp; Anthony J Schaeffer
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  Antigen-specific responses accelerate bacterial clearance in the bladder.

Authors:  Praveen Thumbikat; Carl Waltenbaugh; Anthony J Schaeffer; David J Klumpp
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

Review 10.  Lipid A modification systems in gram-negative bacteria.

Authors:  Christian R H Raetz; C Michael Reynolds; M Stephen Trent; Russell E Bishop
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

View more
  9 in total

1.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

2.  Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.

Authors:  Javiera Vera-Mansilla; Patricio Sánchez; Cecilia A Silva-Valenzuela; Roberto C Molina-Quiroz
Journal:  Microbiol Spectr       Date:  2022-02-16

3.  Lipopolysaccharide reduces urethral smooth muscle contractility via cyclooxygenase activation.

Authors:  Fabiano B Calmasini; Eduardo C Alexandre; Mariana G Oliveira; Fábio H Silva; António G Soares; Soraia K P Costa; Edson Antunes
Journal:  J Physiol Biochem       Date:  2021-05-21       Impact factor: 4.158

4.  Genome-wide analysis of fitness-factors in uropathogenic Escherichia coli during growth in laboratory media and during urinary tract infections.

Authors:  Vanesa García; Rasmus B Grønnemose; Sergi Torres-Puig; Egle Kudirkiene; Mateo Piantelli; Shahana Ahmed; Thomas E Andersen; Jakob Møller-Jensen; John E Olsen; Ana Herrero-Fresno
Journal:  Microb Genom       Date:  2021-12

5.  Genetic and antimicrobial resistance profiles of non-O157 Shiga toxin-producing Escherichia coli from different sources in Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Samah Mahmoud Eldsouky; Tamer Roshdy; Abeer Mohamed Ahmed Bayoume; Ghada M Nasr; Ali S A Salama; Behiry A Akl; Al Shaimaa Hasan; Amany Kasem Shahat; Rana Atef Khashaba; Walid Abdellatif Abdelhalim; Hend E Nasr; Lina Abdelhady Mohammed; Ahmed Salah
Journal:  BMC Microbiol       Date:  2021-09-23       Impact factor: 3.605

6.  Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.

Authors:  Jacob J Zulk; Justin R Clark; Samantha Ottinger; Mallory B Ballard; Marlyd E Mejia; Vicki Mercado-Evans; Emmaline R Heckmann; Belkys C Sanchez; Barbara W Trautner; Anthony W Maresso; Kathryn A Patras
Journal:  mSphere       Date:  2022-08-03       Impact factor: 5.029

7.  Role of aggregate-forming pilus (AFP) in adherence and colonization of both intestinal and urinary tracts.

Authors:  Paulo A Schüroff; Cecilia M Abe; Jonatas W Silva; Cidéli de Paula Coelho; Fernanda B Andrade; Rodrigo T Hernandes; Ulrich Dobrindt; Tânia A T Gomes; Waldir P Elias
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

8.  Deficiency of exopolysaccharides and O-antigen makes Halomonas bluephagenesis self-flocculating and amenable to electrotransformation.

Authors:  Tong Xu; Junyu Chen; Ruchira Mitra; Lin Lin; Zhengwei Xie; Guo-Qiang Chen; Hua Xiang; Jing Han
Journal:  Commun Biol       Date:  2022-06-24

Review 9.  UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.

Authors:  Maria E Terlizzi; Giorgio Gribaudo; Massimo E Maffei
Journal:  Front Microbiol       Date:  2017-08-15       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.